UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041317
Receipt number R000046823
Scientific Title The study of oral treatment japanese treditional medicine Hainosankyuto for infectios epidermal cyst(infectious atheroma)
Date of disclosure of the study information 2020/08/05
Last modified on 2020/08/05 00:30:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The study of japanese traditonal medicine Kampo treatment for atheroma

Acronym

oral treatment of japanese traditional medicine for atheroma

Scientific Title

The study of oral treatment japanese treditional medicine Hainosankyuto for infectios epidermal cyst(infectious atheroma)

Scientific Title:Acronym

The study of Hainosankuto for infectious epidermal cyst

Region

Japan


Condition

Condition

infectious epidermal cyst

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Epidermal cyst sometimes causes severe bacterial infection and need incisional drainage under local anesthesia. We reviewed the short-term outcome of the severe infectious epidermal cyst(IEC) patients with the Japanese traditional medicine, Hainosankyuto, instead of surgical drainage.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The elimination of inflammatory symptom and no recurrence for a year defined short term cure and comparisons were made in cure rate and the internal use period, depending on gender, age, affected area, premedication antibiotics, and complication immunosuppressive disease.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with severely infected epidermal cysts who visited the clinic from January 1, 2013 to December 31, 2018 and need surgical drainage but wish to receive Chinese medicine due to frequent visits

Key exclusion criteria

1. Patients who do not understand the contents of informed consent
2. Patients who have difficulty taking oral medicine for physical reasons
3. Patients who have difficulty taking oral medicine due to mental reasons and mental illness
4. Patients with severe liver or renal damage
5. Patients who have been allergic to this drug
6. Patients who did not obtain the patient's consent

Target sample size

130


Research contact person

Name of lead principal investigator

1st name akiyo
Middle name
Last name gushi

Organization

Gushi dermatology clinic

Division name

dermatology

Zip code

8950075

Address

45-3 Higashiohsyoji, Satsumasendai city, Kagoshima

TEL

0996229412

Email

ruru0601@me.com


Public contact

Name of contact person

1st name akiyo
Middle name
Last name gushi

Organization

Gushi dermatology clinic

Division name

dermatology

Zip code

8950075

Address

45-3 Higashiohsyoji, Satsumasendai city, Kagoshima

TEL

0996229412

Homepage URL


Email

ruru0601@me.com


Sponsor or person

Institute

Gushi dermatology clinic

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kagoshima University Clinical Research Ethics Committee

Address

8-35-1 Sakuragaoka , Kagoshima City, Kagoshima

Tel

0992756624

Email

crmc@m2.kufm.kagoshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人具志ひふ科クリニック(鹿児島県)


Other administrative information

Date of disclosure of the study information

2020 Year 08 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

130

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 06 Month 21 Day

Date of IRB

2020 Year 06 Month 21 Day

Anticipated trial start date

2020 Year 07 Month 30 Day

Last follow-up date

2020 Year 07 Month 30 Day

Date of closure to data entry

2020 Year 07 Month 30 Day

Date trial data considered complete

2020 Year 07 Month 30 Day

Date analysis concluded

2020 Year 07 Month 30 Day


Other

Other related information

observational study


Management information

Registered date

2020 Year 08 Month 05 Day

Last modified on

2020 Year 08 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046823


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name